ArticleNPJ breast cancer2022

A biomarker of aging, p16, predicts peripheral neuropathy in women receiving adjuvant taxanes for breast cancer.

Natalia Mitin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.